In a 25‑day‑old male infant with a hyperechoic ill‑defined left shoulder mass containing small internal cystic spaces that may represent fat necrosis, what is the appropriate next step in management?

Management of Hyperechoic Shoulder Mass in a 25-Day-Old Infant

The appropriate next step is clinical observation with close monitoring for complications, specifically serial calcium measurements to screen for hypercalcemia, which is the most serious complication of subcutaneous fat necrosis of the newborn (SFNN).

Initial Diagnostic Approach

The clinical presentation—a hyperechoic ill-defined mass with small internal cystic spaces in a neonate—is highly consistent with subcutaneous fat necrosis of the newborn 1. Ultrasound is the imaging modality of choice for confirming this diagnosis because it provides excellent resolution of superficial lesions, requires no sedation, and avoids ionizing radiation 2, 1.

Key Clinical Features to Assess

• Timing: SFNN typically presents within the first 6 weeks of life, with median onset at day 6 (range 1-70 days) 3
• Perinatal history: Look specifically for birth asphyxia, therapeutic hypothermia, hypoglycemia, or other neonatal stress—78% of cases have documented asphyxia 3
• Physical examination: Lesions typically manifest as indurated subcutaneous plaques or nontender mobile nodules, sometimes with skin discoloration, with predilection for pressure areas 1
• Distribution: Most commonly affects the back (87.5%), upper extremities (43.8%), and lower extremities (43.8%) 4

Management Strategy

Immediate Actions

• Serial calcium monitoring: Begin immediately and continue for at least 6 months, as hypercalcemia develops in 53% of cases with median onset at day 28 (range 1-210 days) 3
• Baseline laboratory evaluation: Obtain calcium, parathyroid hormone, and vitamin D levels 3
• Clinical observation: The skin lesions typically resolve spontaneously with median duration of 62 days (range 14-390 days) 3

Monitoring Protocol

Close surveillance is essential because 52% of hypercalcemia cases are asymptomatic 3. The hypercalcemia results from suppressed parathyroid hormone and vitamin D 3.

• Physical examination every 2-4 weeks to assess lesion progression
• Serial calcium measurements weekly for the first month, then every 2 weeks for 6 months 3
• If hypercalcemia develops: initiate hyperhydration and furosemide therapy 3

When Additional Imaging Is NOT Indicated

Do not perform routine advanced imaging (CT or MRI) for suspected SFNN 2. The diagnosis is primarily clinical and confirmed by ultrasound 1. Advanced imaging should be reserved only for:

• Diagnostic uncertainty after ultrasound evaluation 2
• Concern for alternative diagnoses (vascular malformations, tumors) 2
• Evaluation of associated structural abnormalities in specific syndromes 2

Surgical Intervention Considerations

Surgery is rarely indicated and should be reserved for exceptional circumstances 4, 5:

• Lack of improvement after 9 months of observation 5
• Extensive calcifications causing functional impairment 5
• Persistent symptomatic lesions beyond the expected resolution timeframe 4

In the systematic review of surgically managed cases, average age at surgery was 39.5 days, but most cases (87%) resolve completely without intervention 4.

Critical Pitfalls to Avoid

• Do not biopsy: The diagnosis is clinical and radiologic; biopsy is unnecessary and risks complications 1
• Do not assume benign course: Despite self-limited skin lesions, hypercalcemia can be life-threatening and requires prolonged medical treatment 3, 6
• Do not discontinue monitoring prematurely: Hypercalcemia can develop late (up to 210 days) and may require prolonged treatment with low-calcium formula 3
• Do not expose to unnecessary radiation: CT provides no additional diagnostic benefit over ultrasound for SFNN and exposes the infant to ionizing radiation 2, 1

Differential Considerations

While the imaging characteristics strongly suggest SFNN, maintain awareness of alternative diagnoses including 2:

• Infantile hemangioma (though these typically appear as well-defined high-flow masses on ultrasound) 2
• Vascular malformations (would show different flow characteristics on Doppler) 2
• Lipoma (would appear intensely hyperechoic and homogeneous) 2

The presence of internal cystic spaces and ill-defined margins in a neonate with appropriate risk factors makes SFNN the most likely diagnosis 1.